Brand/Generic Settlements May Get Supreme Court Review In Tamoxifen Case
The U.S. Supreme Court may take up the question of whether reverse settlements between brand and generic companies can violate antitrust laws
The U.S. Supreme Court may take up the question of whether reverse settlements between brand and generic companies can violate antitrust laws